We previously demonstrated that quantitative immunohistochemistry (Q-IHC) performed by measuring the cumulative signal strength of the digital file encoding an image can be used to determine the absolute amount of chromogen present per pixel. We now show that Q-IHC so performed can be used to accurately determine the amount of peptide hormone receptor of interest in archived tissues. To do this we transfected Balb 3T3 fibroblasts with the cDNA encoding the human receptor for gastrin-releasing peptide (GRP), and selected six cell lines stably expressing between 10(2) and 10(6) receptors/cell. These cell lines were fixed in formalin, embedded in paraffin, and treated with antipeptide antibodies against the GRP receptor, followed by DAB chromogen to identify bound antibody. Images were acquired using a 4.9 million pixel digital scanning 24-bit RGB camera, saved in TIFF format, and used for subsequent analysis. Q-IHC was performed after digitally dissecting out the relevant portion of the image for analysis, and processing using a program written in C (available at http://www.uic.edu/com/dom/gastro/Freedownloads.html). Under the conditions defined here, chromogen quantity as determined by Q-IHC tightly correlated with GRP receptor number (r(2)=0.867) in these cell lines. Using the conversion factor identified as a result of these studies, we then determined GRP receptor number on eight randomly selected, archived human colon cancers. Overall GRP receptor expression in colon cancer depended on the degree to which cells within any particular tumor were differentiated, with well-differentiated cells expressing the greatest numbers of receptors (approximately 55,000 +/- 10,000 sites/cell). These studies indicate that Q-IHC can be used to determine receptor quantity in archived tissues and other samples of limited quantity.

Download full-text PDF

Source
http://dx.doi.org/10.1177/002215540305100209DOI Listing

Publication Analysis

Top Keywords

grp receptor
16
receptor number
12
q-ihc performed
12
cell lines
12
quantitative immunohistochemistry
8
measuring cumulative
8
cumulative signal
8
signal strength
8
receptor
8
archived tissues
8

Similar Publications

Peptide-drug conjugates (PDCs) have recently gained significant attention for the targeted delivery of anticancer therapeutics, mainly due to their cost-effective and chemically defined production and lower antigenicity compared to ADCs, among other benefits. In this study, we designed and synthesized novel PDCs by conjugating new thiol-functionalized tubulysin analogs (tubugis) to bombesin, a peptide ligand with a relevant role in cancer research. Two tubulysin analogs bearing ready-for-conjugation thiol groups were prepared by an on-resin multicomponent peptide synthesis strategy and subsequently tested for their stand-alone anti-proliferative activity against human cancer cells, which resulted in IC values in the nanomolar range.

View Article and Find Full Text PDF

Prostate cancer (PC) represents the second most diagnosed form of cancer in men on a global scale. Despite the theranostic efficacy of prostate-specific membrane antigen (PSMA) radioligands, there is a spectrum of PC disease in which PSMA expression is low or absent. The gastrin-releasing peptide receptor (GRPR), also known as the bombesin type 2 receptor, has been identified as a target in both the early and advanced stages of PC.

View Article and Find Full Text PDF
Article Synopsis
  • Prostate cancer (PCa) is a common cancer in men, and this study introduces iron oxide nanoparticles (IONs) designed to target the overexpressed Prostate Specific Membrane Antigen (PSMA) and Gastrin Releasing Peptide (GRP) receptors in PCa for better treatment options.
  • The researchers created different functionalized IONs that were tested for size, functionality, and radiolabeling efficiency, finding them to bind effectively to PCa cells while showing low toxicity.
  • The results indicate these Tc-radiolabeled IONs are stable and could be developed as diagnostic tools for PCa using Single Photon Emission Computed Tomography (SPECT) imaging.
View Article and Find Full Text PDF
Article Synopsis
  • The suprachiasmatic nucleus (SCN) in the hypothalamus is the central control hub for circadian rhythms in mammals, producing various neurotransmitters.
  • Researchers confirmed the presence of β-adrenergic receptors in the SCN and examined their effects on energy signaling through cAMP-regulated elements.
  • The study's findings suggest that stress-related increases in adrenaline can impact circadian functions and may help explain side effects of β-blockers used for hypertension.
View Article and Find Full Text PDF

Recent Advances in Pre-Clinical Development of Adiponectin Receptor Agonist Therapies for Duchenne Muscular Dystrophy.

Biomedicines

June 2024

School of Kinesiology and Health Science, Muscle Health Research Centre, York University, Toronto, ON M3J 1P3, Canada.

Duchenne muscular dystrophy (DMD) is caused by genetic mutations in the cytoskeletal-sarcolemmal anchor protein dystrophin. Repeated cycles of sarcolemmal tearing and repair lead to a variety of secondary cellular and physiological stressors that are thought to contribute to weakness, atrophy, and fibrosis. Collectively, these stressors can contribute to a pro-inflammatory milieu in locomotor, cardiac, and respiratory muscles.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!